Compare

Butterfly Network, Inc. vs NeuroPace Inc vs Kestra Medical Technologies, Ltd. vs Beta Bionics, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearButterfly Network, Inc.
BFLY
NeuroPace Inc
NPCE
Kestra Medical Technologies, Ltd.
KMTS
Beta Bionics, Inc.
BBNX
Year ended2025-12-312025-12-312026-04-302025-12-31
Revenue$97.61M$99.99M$95.13M$100.25M
Revenue growth (YoY)+19.0%+25.1%+59.0%+53.9%
Gross margin46.9%77.2%51.4%55.4%
Operating margin-88.5%-16.3%-141.6%-71.5%
Net margin-79.0%-21.5%-138.4%-73.0%
Net income-$77.06M-$21.46M-$131.61M-$73.20M
EPS (Diluted)-$0.31-$0.66-$2.43-$1.81
Operating cash flow-$12.70M-$11.01M-$81.70M-$50.92M
Free cash flow-$16.05M-$11.34M-$116.59M-$56.22M
Cash & equivalents$150.49M$21.69M$99.71M$31.58M
Total assets$296.53M$105.56M$358.46M$328.74M
Total liabilities$100.55M$86.53M$98.81M$41.13M
Shareholders' equity$195.98M$19.03M$259.66M$287.61M
Return on year-end equity-39.3%-112.8%-50.7%-25.5%
Shares outstandingn/a33.57M58.38M44.36M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearButterfly Network, Inc.NeuroPace IncKestra Medical Technologies, Ltd.Beta Bionics, Inc.
Latest$97.61M
Ended 2025-12-31
$99.99M
Ended 2025-12-31
$95.13M
Ended 2026-04-30
$100.25M
Ended 2025-12-31
1 year earlier$82.06M
Ended 2024-12-31
$79.91M
Ended 2024-12-31
$59.81M
Ended 2025-04-30
$65.12M
Ended 2024-12-31
2 years earlier$65.90M
Ended 2023-12-31
$65.42M
Ended 2023-12-31
$27.81M
Ended 2024-04-30
$11.99M
Ended 2023-12-31
3 years earlier$73.39M
Ended 2022-12-31
$45.52M
Ended 2022-12-31
n/an/a
4 years earlier$62.56M
Ended 2021-12-31
$45.18M
Ended 2021-12-31
n/an/a